Alector

Contact us to add description: recruit@workinbiotech.com

Contact us to add description: recruit@workinbiotech.com

Alector is developing therapies for the treatment of neurodegenerative diseases. Despite the rise in the number of patients suffering with brain disorders there is still a lack of effective therapeutics. Immune cells in the brain are important for brain health. By combining antibody technology, human genetics and the latest insights in neuroscience, Alector is building a pipeline of therapeutics to harness the body’s own immune system to heal itself. This immuno-neurology strategy is analogous to current immuno-oncology approaches to activate and recruit the adaptive immune response. Through partnering with other companies such as GSK, Alector currently has many therapeutics in Phase 1-3 clinical trials for dementia and Alzheimer’s disease.

Jobs: